These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18521870)

  • 21. Role of lipid emulsion administration in acute lung injury during liver transplant rejection: a case report.
    Kostopanagiotou G; Kalimeris K; Arkadopoulos N; Karakitsos P; Smyrniotis V; Pandazi A
    Transplant Proc; 2008 Dec; 40(10):3823-5. PubMed ID: 19100504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes.
    McCaughan GW; Shackel NA; Bertolino P; Bowen DG
    Transplantation; 2009 Apr; 87(8):1105-11. PubMed ID: 19384153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients.
    Sánchez-Pérez B; Aranda Narváez JM; Santoyo Santoyo J; Fernández-Aguilar JL; Suárez Muñoz MA; González-Sánchez AJ; Pérez Daga JA; Ramírez Plaza CP; Carrasco Campos J; Jiménez Mazure C; Becerra Ortíz R
    Transplant Proc; 2008 Nov; 40(9):2994-6. PubMed ID: 19010171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Previous intravenous substance use and outcome of liver transplantation in patients with chronic hepatitis C infection.
    Robaeys G; Nevens F; Stärkel P; Colle I; Van Eyken P; Bruckers L; Van Ranst M; Buntinx F
    Transplant Proc; 2009 Mar; 41(2):589-94. PubMed ID: 19328933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
    Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J
    Transplantation; 2009 Jun; 87(12):1877-83. PubMed ID: 19543068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus and liver transplantation: our point of view.
    Di Benedetto F; Di Sandro S; De Ruvo N; Berretta M; Montalti R; Guerrini GP; Ballarin R; De Blasiis MG; Spaggiari M; Smerieri N; Iemmolo RM; Guaraldi G; Gerunda GE
    Transplant Proc; 2008; 40(6):1965-71. PubMed ID: 18675102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does interferon use prior to liver transplant influence hepatitis C outcomes following transplantation?
    Smallwood GA; Devine R; Fasola C; Stieber AC; Heffron TG
    Transplantation; 2008 Dec; 86(12):1795-8. PubMed ID: 19104424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C and renal transplantation: a review on historical aspects and current issues.
    Moghaddam SM; Alavian SM; Kermani NA
    Rev Med Virol; 2008; 18(6):375-86. PubMed ID: 18702126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent autoimmune hepatitis after liver transplantation: a disease continuum or a fresh start?
    Czaja AJ
    Liver Transpl; 2009 Oct; 15(10):1169-71. PubMed ID: 19790163
    [No Abstract]   [Full Text] [Related]  

  • 31. Is cyclosporin the immunosuppressant of choice for liver transplantation for erythropoietic protoporphyria?
    Nash KL; Cox TM; Alexander GJ
    Transpl Int; 2008 Feb; 21(2):192-3. PubMed ID: 17944799
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.
    Almutairi F; Peterson TC; Molinari M; Walsh MJ; Alwayn I; Peltekian KM
    Liver Transpl; 2009 May; 15(5):504-8. PubMed ID: 19399742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [3/12. Drugs and renal and hepatic transplant patients].
    Berg C; Woronoff-Lemsi MC
    Soins; 2001 May; (655):47-8. PubMed ID: 12008498
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of liver transplant recipients with recurrent hepatitis C.
    McCashland TM
    Curr Opin Organ Transplant; 2009 Jun; 14(3):221-4. PubMed ID: 19444107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of living donor liver transplant patients using twice-daily 4-hour intravenous cyclosporine therapy.
    Sato K; Iwane T; Sekiguchi S; Nakamura A; Akamatsu Y; Kawagishi N; Miyagi S; Takeda I; Sato A; Fujimori K; Satomi S
    Transplant Proc; 2009; 41(1):229-32. PubMed ID: 19249521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinsonism during cyclosporine treatment in liver transplantation: an unusual case report.
    Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Sato A; Fujimori K; Satomi S
    Transplant Proc; 2008 Oct; 40(8):2823-4. PubMed ID: 18929871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients.
    Pourfarziani V; Taheri S
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):991-4. PubMed ID: 19861858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
    Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
    Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.